CERENO SCIENTIFIC AB B Financial Flexibility Index
CERENO SCIENTIFIC AB B financial flexibility index. CERENO SCIENTIFIC AB B (4A1) has a Financial Flexibility Index of 0.28x as of June 2026. Free cash flow of €73.34 Million (operating CF €20.90 Million minus capex €52.44 Million) represents 0% of total liabilities (€261.12 Million). See 4A1 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CERENO SCIENTIFIC AB B (2021–2025)
Financial flexibility index of CERENO SCIENTIFIC AB B from 2021 to 2025. Historical Financial Flexibility Index trend for CERENO SCIENTIFIC AB B across 5 annual periods. Explore how well can CERENO SCIENTIFIC AB B service its debt to assess how comfortably operating cash covers total debt obligations.
CERENO SCIENTIFIC AB B Financial Flexibility Index by Year (2021–2025)
CERENO SCIENTIFIC AB B financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for CERENO SCIENTIFIC AB B. For the full cash flow conversion analysis, see CERENO SCIENTIFIC AB B operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.45x | €-67.59 Million | €-111.93 Million | €150.08 Million | ▼ -435.8% |
| 2024 | -0.08x | €-18.65 Million | €-103.42 Million | €221.85 Million | ▼ -146.6% |
| 2023 | 0.18x | €12.36 Million | €-36.92 Million | €68.56 Million | ▼ -93.4% |
| 2022 | 2.75x | €38.92 Million | €-18.62 Million | €14.14 Million | ▼ -7.2% |
| 2021 | 2.97x | €31.67 Million | €-13.14 Million | €10.67 Million | — |